Diffuse histiocytic lymphoma complicating chronic lymphocytic leukemia

James O. Armitage, Fred R. Dick, Michael P. Corder

Research output: Contribution to journalArticle

85 Citations (Scopus)

Abstract

Nine patients with chronic lymphocytic leukemia (CLL) who also developed diffuse histiocytic lymphoma (DH) are described. The incidence of patients with CLL developing DH was at least 3.3%. CLL existed for a median of 2 years before the diagnosis of DH. DH presented in 8 patients with abdominal symptoms and/or enlarging lymph nodes, spleen and liver. There were no consistent laboratory abnormalities associated with the onset of DH. In 4 of the patients the DH appeared to be localized. Eight of the 9 patients have died with a median survival of 2 months from the diagnosis of DH. Whether DH occurs as a result of „blastic transformation” of pre‐existing CLL or is a second, unrelated malignancy is not certain. It is hypothesized that utilizing current therapies for DH might favorably influence survival.

Original languageEnglish (US)
Pages (from-to)422-427
Number of pages6
JournalCancer
Volume41
Issue number2
DOIs
StatePublished - Feb 1978

Fingerprint

Lymphoma, Large B-Cell, Diffuse
B-Cell Chronic Lymphocytic Leukemia
Survival
Second Primary Neoplasms
Spleen
Lymph Nodes
Liver
Incidence

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Diffuse histiocytic lymphoma complicating chronic lymphocytic leukemia. / Armitage, James O.; Dick, Fred R.; Corder, Michael P.

In: Cancer, Vol. 41, No. 2, 02.1978, p. 422-427.

Research output: Contribution to journalArticle

Armitage, James O. ; Dick, Fred R. ; Corder, Michael P. / Diffuse histiocytic lymphoma complicating chronic lymphocytic leukemia. In: Cancer. 1978 ; Vol. 41, No. 2. pp. 422-427.
@article{dc3eb7b24c6243d78fdb7daa950c82bb,
title = "Diffuse histiocytic lymphoma complicating chronic lymphocytic leukemia",
abstract = "Nine patients with chronic lymphocytic leukemia (CLL) who also developed diffuse histiocytic lymphoma (DH) are described. The incidence of patients with CLL developing DH was at least 3.3{\%}. CLL existed for a median of 2 years before the diagnosis of DH. DH presented in 8 patients with abdominal symptoms and/or enlarging lymph nodes, spleen and liver. There were no consistent laboratory abnormalities associated with the onset of DH. In 4 of the patients the DH appeared to be localized. Eight of the 9 patients have died with a median survival of 2 months from the diagnosis of DH. Whether DH occurs as a result of „blastic transformation” of pre‐existing CLL or is a second, unrelated malignancy is not certain. It is hypothesized that utilizing current therapies for DH might favorably influence survival.",
author = "Armitage, {James O.} and Dick, {Fred R.} and Corder, {Michael P.}",
year = "1978",
month = "2",
doi = "10.1002/1097-0142(197802)41:2<422::AID-CNCR2820410207>3.0.CO;2-X",
language = "English (US)",
volume = "41",
pages = "422--427",
journal = "Cancer",
issn = "0008-543X",
publisher = "John Wiley and Sons Inc.",
number = "2",

}

TY - JOUR

T1 - Diffuse histiocytic lymphoma complicating chronic lymphocytic leukemia

AU - Armitage, James O.

AU - Dick, Fred R.

AU - Corder, Michael P.

PY - 1978/2

Y1 - 1978/2

N2 - Nine patients with chronic lymphocytic leukemia (CLL) who also developed diffuse histiocytic lymphoma (DH) are described. The incidence of patients with CLL developing DH was at least 3.3%. CLL existed for a median of 2 years before the diagnosis of DH. DH presented in 8 patients with abdominal symptoms and/or enlarging lymph nodes, spleen and liver. There were no consistent laboratory abnormalities associated with the onset of DH. In 4 of the patients the DH appeared to be localized. Eight of the 9 patients have died with a median survival of 2 months from the diagnosis of DH. Whether DH occurs as a result of „blastic transformation” of pre‐existing CLL or is a second, unrelated malignancy is not certain. It is hypothesized that utilizing current therapies for DH might favorably influence survival.

AB - Nine patients with chronic lymphocytic leukemia (CLL) who also developed diffuse histiocytic lymphoma (DH) are described. The incidence of patients with CLL developing DH was at least 3.3%. CLL existed for a median of 2 years before the diagnosis of DH. DH presented in 8 patients with abdominal symptoms and/or enlarging lymph nodes, spleen and liver. There were no consistent laboratory abnormalities associated with the onset of DH. In 4 of the patients the DH appeared to be localized. Eight of the 9 patients have died with a median survival of 2 months from the diagnosis of DH. Whether DH occurs as a result of „blastic transformation” of pre‐existing CLL or is a second, unrelated malignancy is not certain. It is hypothesized that utilizing current therapies for DH might favorably influence survival.

UR - http://www.scopus.com/inward/record.url?scp=0017883241&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0017883241&partnerID=8YFLogxK

U2 - 10.1002/1097-0142(197802)41:2<422::AID-CNCR2820410207>3.0.CO;2-X

DO - 10.1002/1097-0142(197802)41:2<422::AID-CNCR2820410207>3.0.CO;2-X

M3 - Article

C2 - 343908

AN - SCOPUS:0017883241

VL - 41

SP - 422

EP - 427

JO - Cancer

JF - Cancer

SN - 0008-543X

IS - 2

ER -